UT Health San Antonio’s new $472 million Multispecialty and Research Hospital is envisioned as “a place of firsts,” a symbol of “hope for the hopeless” that will expand the reach of the growing, ...

Training for the proprietary program is aimed at implementing the latest evidenced-based approaches to dementia care amid the ...

Training for the proprietary program is aimed at implementing the latest evidenced-based approaches to dementia care amid the ...

A visit to a groundbreaking Swedish exhibition revealed how innovative design, particularly specialised jackets, could ...

Caring for people living with dementia has always required balancing safety and autonomy: We often want autonomy for ...

Cassava Sciences has faced a lot of scrutiny, with key figures resigning and the company settling an SEC penalty. Read what ...

Top-line Data for RETHINK-ALZ 52-week Phase 3 trial Expected Before the End of 2024$149.0 Million in Cash and Cash Equivalents at September 30, ...

Some of these structures are enormous monoliths intended to humble us, while others are warm, pedestrian-scale buildings meant to reassure us—and we kinda love them all.

November 7, 2024. More for You ...

Hilary Evans-Newton is the Chief Executive of Alzheimer’s Research UK. Hilary joined Alzheimer’s Research UK in 2013 and has overseen significant growth in income in recent years, which has ...

These are available on the NHS. This type of medication is prescribed to people with mild symptoms of Alzheimer's or dementia with Lewy bodies. These are: donepezil (Aricept) rivastigmine (Exelon) ...

Anavex Life Sciences' (AVXL) stock surged on new Alzheimer's trial data, but data's inconsistency raises concerns, making the ...